Incidence of Parkinson's disease in a large patient cohort with idiopathic smell and taste loss.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 21 09 2018
accepted: 20 11 2018
revised: 19 11 2018
pubmed: 30 11 2018
medline: 29 5 2019
entrez: 30 11 2018
Statut: ppublish

Résumé

Patients with idiopathic smell loss constitute an at-risk population for the development of Parkinson's disease (PD). The study aimed to follow up a large number of patients with idiopathic smell and/or taste loss to define the incidence of PD in this population and, further, to assess characteristics of both olfactory and gustatory function and their possible association with PD development. In this prospective case-control study, 833 patients diagnosed with an idiopathic smell disorder at our Smell and Taste Center during the last 15 years were contacted for a telephone interview. In 474 patients, a complete data set containing of demographic data, clinical information, retrospective smell and taste testing results, and telephone assessment was obtained. Out of 474 patients with idiopathic smell loss 45 (9.8%) had been diagnosed with PD, since they received the diagnosis of idiopathic smell and/or taste loss (mean 10.9 years after olfactory loss onset). Thus, with respect to the classification into olfactory/gustatory disorders, 28.6% of the patients with a combined olfactory and gustatory disorder developed PD, whereas in 9.9% of those with a pure olfactory disorder and in 3.8% of those with a pure gustatory disorder, PD was diagnosed. No association emerged between qualitative smell or taste loss and PD development. This large patient cohort study extends the previous literature, indicating that risk stratification might be considerably improved by correct diagnostic allocation and emphasizes the need for an exhaustive olfactory and gustatory assessment in specialized centers.

Identifiants

pubmed: 30488238
doi: 10.1007/s00415-018-9135-x
pii: 10.1007/s00415-018-9135-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-345

Références

Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Ann Neurol. 2004 Aug;56(2):173-81
pubmed: 15293269
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):40-6
pubmed: 15607993
J Neurol Sci. 2006 Oct 25;248(1-2):177-84
pubmed: 16769086
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43
pubmed: 17021776
Mov Disord. 2007 Apr 30;22(6):839-42
pubmed: 17357143
Ann Neurol. 2008 Feb;63(2):167-73
pubmed: 18067173
Parkinsonism Relat Disord. 2009 Mar;15(3):232-7
pubmed: 18606556
Parkinsonism Relat Disord. 2009 Aug;15(7):490-4
pubmed: 19138875
Mov Disord. 2009 Apr 30;24(6):906-14
pubmed: 19205070
Neurology. 2009 Feb 17;72(7 Suppl):S21-6
pubmed: 19221310
J Neurol. 2009 Feb;256(2):242-8
pubmed: 19221845
Mov Disord. 2009 May 15;24(7):1060-5
pubmed: 19353591
Parkinsonism Relat Disord. 2010 Feb;16(2):79-84
pubmed: 19846332
Mov Disord. 2009;24 Suppl 2:S656-64
pubmed: 19877243
ORL J Otorhinolaryngol Relat Spec. 2010;72(5):252-5
pubmed: 20714205
QJM. 2010 Dec;103(12):941-52
pubmed: 20736182
J Neurol. 2011 Jun;258(6):1076-9
pubmed: 21193922
Mov Disord. 2011 Mar;26(4):653-8
pubmed: 21370256
J Neurol Sci. 2011 Nov 15;310(1-2):21-4
pubmed: 21705022
Intern Med. 2011;50(20):2311-5
pubmed: 22001456
Eur J Neurol. 2013 Jan;20(1):102-8
pubmed: 22852790
J Neural Transm (Vienna). 2014 Feb;121(2):119-22
pubmed: 24078166
Mov Disord. 2015 Feb;30(2):229-37
pubmed: 25449044
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
J Neurol. 2017 Jun;264(6):1236-1246
pubmed: 28550478
Neurology. 2017 Oct 3;89(14):1441-1447
pubmed: 28878051
Neurology. 2018 May 15;90(20):940
pubmed: 29759998
Neurology. 1988 Aug;38(8):1237-44
pubmed: 3399075
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46
pubmed: 9153598
J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):314-9
pubmed: 9527140

Auteurs

Antje Haehner (A)

Department of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, 01307, Dresden, Germany. antje.haehner@uniklinikum-dresden.de.

Carla Masala (C)

Section of Physiology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.

Sophie Walter (S)

Department of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, 01307, Dresden, Germany.

Heinz Reichmann (H)

Department of Neurology, TU Dresden, 01307, Dresden, Germany.

Thomas Hummel (T)

Department of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, 01307, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH